Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Canton. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Canton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
The study is designed to assess whether glufosfamide provides additional survival benefit as compared to bolus 5-FU in patients with metastatic pancreatic cancer who have already progressed or failed therapy on a gemcitabine based first line regimen.
Sponsor: Eleison Pharmaceuticals LLC.
Check if you qualify for this pancreatic cancer clinical trial in Canton, OH
If you're searching for pancreatic cancer treatment options in Canton, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Canton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.